IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 191 filers reported holding IMMUNOVANT INC in Q3 2023. The put-call ratio across all filers is 2.28 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,173,275 | -87.6% | 30,562 | -94.3% | 0.00% | -98.3% |
| Q4 2022 | $9,475,660 | +913.4% | 533,840 | +218.6% | 0.17% | +861.1% |
| Q3 2022 | $935,000 | +232.7% | 167,570 | +408.5% | 0.02% | +100.0% |
| Q4 2021 | $281,000 | +103.6% | 32,956 | +108.1% | 0.01% | +125.0% |
| Q3 2021 | $138,000 | -62.8% | 15,835 | -54.9% | 0.00% | -69.2% |
| Q2 2021 | $371,000 | -42.0% | 35,145 | -11.9% | 0.01% | -64.9% |
| Q1 2021 | $640,000 | – | 39,886 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 4,448,017 | $17,347,000 | 4.39% |
| Deep Track Capital, LP | 9,455,000 | $36,875,000 | 2.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233 | $60,000,000 | 0.63% |
| Octagon Capital Advisors LP | 579,061 | $2,258,000 | 0.60% |
| Eventide Asset Management | 5,372,512 | $20,953,000 | 0.45% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 174,000 | $679,000 | 0.29% |
| Frazier Life Sciences Management, L.P. | 585,759 | $2,284,000 | 0.22% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $212,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 777,590 | $3,033,000 | 0.12% |
| Bridgefront Capital, LLC | 15,649 | $61,000 | 0.07% |